Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 271

1.

Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.

Genitsch V, Kollár A, Vandekerkhove G, Blarer J, Furrer M, Annala M, Herberts C, Pycha A, de Jong JJ, Liu Y, Krentel F, Davicioni E, Gibb EA, Kruithof-de Julio M, Wyatt AW, Seiler R.

Urol Oncol. 2019 Oct 1. pii: S1078-1439(19)30376-X. doi: 10.1016/j.urolonc.2019.09.025. [Epub ahead of print]

PMID:
31585777
2.

Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum.

Nappi L, Thi M, Lum A, Huntsman D, Eigl BJ, Martin C, O'Neil B, Maughan BL, Chi K, So A, Black PC, Gleave M, Wyatt AW, Lavoie JM, Khalaf D, Bell R, Daneshmand S, Hamilton RJ, Leao RRN, Nichols C, Kollmannsberger C.

J Clin Oncol. 2019 Sep 25:JCO1802057. doi: 10.1200/JCO.18.02057. [Epub ahead of print]

PMID:
31553692
3.

TRPC channels regulate Ca2+-signaling and short-term plasticity of fast glutamatergic synapses.

Schwarz Y, Oleinikov K, Schindeldecker B, Wyatt A, Weißgerber P, Flockerzi V, Boehm U, Freichel M, Bruns D.

PLoS Biol. 2019 Sep 19;17(9):e3000445. doi: 10.1371/journal.pbio.3000445. eCollection 2019 Sep.

4.

Alpha-2-Macroglobulin, a Hypochlorite-Regulated Chaperone and Immune System Modulator.

Cater JH, Wilson MR, Wyatt AR.

Oxid Med Cell Longev. 2019 Jul 22;2019:5410657. doi: 10.1155/2019/5410657. eCollection 2019. Review.

5.

Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.

Dugas SG, Müller DC, Le Magnen C, Federer-Gsponer J, Seifert HH, Ruiz C, Savic Prince S, Vlajnic T, Zellweger T, Mertz KD, Bacon JVW, Wyatt AW, Rentsch CA, Bubendorf L.

Cancer Cytopathol. 2019 Sep;127(9):578-585. doi: 10.1002/cncy.22167. Epub 2019 Aug 6.

PMID:
31386310
6.

Widespread Cell-Specific Prolactin Receptor Expression in Multiple Murine Organs.

Aoki M, Wartenberg P, Grünewald R, Phillipps HR, Wyatt A, Grattan DR, Boehm U.

Endocrinology. 2019 Nov 1;160(11):2587-2599. doi: 10.1210/en.2019-00234.

PMID:
31373638
7.

Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.

Genitsch V, Kollár A, Vandekerkhove G, Blarer J, Furrer M, Annala M, Herberts C, Pycha A, de Jong JJ, Liu Y, Krentel F, Davicioni E, Gibb EA, Kruithof-de Julio M, Wyatt AW, Seiler R.

Urol Oncol. 2019 Sep;37(9):573.e19-573.e29. doi: 10.1016/j.urolonc.2019.06.021. Epub 2019 Jul 26.

PMID:
31358384
9.

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.

Alshalalfa M, Liu Y, Wyatt AW, Gibb EA, Tsai HK, Erho N, Lehrer J, Takhar M, Ramnarine VR, Collins CC, Den RB, Schaeffer EM, Davicioni E, Lotan TL, Bismar TA.

Int J Cancer. 2019 May 24. doi: 10.1002/ijc.32430. [Epub ahead of print]

PMID:
31125117
10.

Photodissociation dynamics of CH3I probed via multiphoton ionisation photoelectron spectroscopy.

Warne EM, Downes-Ward B, Woodhouse J, Parkes MA, Bellshaw D, Springate E, Majchrzak P, Zhang Y, Karras G, Wyatt AS, Chapman RT, Kirrander A, Minns RS.

Phys Chem Chem Phys. 2019 Jun 7;21(21):11142-11149. doi: 10.1039/c9cp01477b. Epub 2019 May 16.

PMID:
31094379
11.

Trends in potentially abused medications returned during medication take-back days.

Shealy KM, Ritter MS, Wyatt AS, Eagerton DH.

J Am Pharm Assoc (2003). 2019 Jul - Aug;59(4):575-578. doi: 10.1016/j.japh.2019.04.005. Epub 2019 May 9.

PMID:
31080146
12.

Molecular landscape of carcinoma invading bladder muscle: does patient age matter?

Seiler R, Wyatt AW, Black PC.

BJU Int. 2019 May 9. doi: 10.1111/bju.14802. [Epub ahead of print] No abstract available.

PMID:
31074172
13.

A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.

Hotte SJ, Chi KN, Joshua AM, Tu D, Macfarlane RJ, Gregg RW, Ruether JD, Basappa NS, Finch D, Salim M, Winquist EW, Torri V, North S, Kollmannsberger C, Ellard SL, Eigl BJ, Tinker A, Allan AL, Beja K, Annala M, Powers J, Wyatt AW, Seymour L; Canadian Cancer Trials Group (formerly NCIC Clinical Trials Group).

Clin Genitourin Cancer. 2019 Jun;17(3):201-208.e1. doi: 10.1016/j.clgc.2019.03.005. Epub 2019 Mar 15.

PMID:
31056399
14.

Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer's-associated amyloid beta peptide.

Cater JH, Kumita JR, Zeineddine Abdallah R, Zhao G, Bernardo-Gancedo A, Henry A, Winata W, Chi M, Grenyer BSF, Townsend ML, Ranson M, Buhimschi CS, Charnock-Jones DS, Dobson CM, Wilson MR, Buhimschi IA, Wyatt AR.

Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6101-6110. doi: 10.1073/pnas.1817298116. Epub 2019 Mar 8.

15.

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.

Sundahl N, Vandekerkhove G, Decaestecker K, Meireson A, De Visschere P, Fonteyne V, De Maeseneer D, Reynders D, Goetghebeur E, Van Dorpe J, Verbeke S, Annala M, Brochez L, Van der Eecken K, Wyatt AW, Rottey S, Ost P.

Eur Urol. 2019 May;75(5):707-711. doi: 10.1016/j.eururo.2019.01.009. Epub 2019 Jan 19.

PMID:
30665814
16.

Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.

Vandekerkhove G, Struss WJ, Annala M, Kallio HML, Khalaf D, Warner EW, Herberts C, Ritch E, Beja K, Loktionova Y, Hurtado-Coll A, Fazli L, So A, Black PC, Nykter M, Tammela T, Chi KN, Gleave ME, Wyatt AW.

Eur Urol. 2019 Apr;75(4):667-675. doi: 10.1016/j.eururo.2018.12.042. Epub 2019 Jan 10.

PMID:
30638634
17.

Biomarkers for Programmed Death-1 Inhibition in Prostate Cancer.

Manogue C, Cotogno P, Ledet E, Lewis B, Wyatt AW, Sartor O.

Oncologist. 2019 Apr;24(4):444-448. doi: 10.1634/theoncologist.2018-0546. Epub 2018 Dec 12.

18.

Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy.

da Costa JB, Gibb EA, Nykopp TK, Mannas M, Wyatt AW, Black PC.

Urol Oncol. 2018 Dec 8. pii: S1078-1439(18)30463-0. doi: 10.1016/j.urolonc.2018.11.015. [Epub ahead of print] Review.

PMID:
30528886
19.

Spatially resolved common-path high-order harmonic interferometry.

Mang MM, Lloyd DT, Anderson PN, Treacher D, Wyatt AS, Hooker SM, Walmsley IA, O'Keeffe K.

Opt Lett. 2018 Nov 1;43(21):5275-5278. doi: 10.1364/OL.43.005275.

PMID:
30382986
20.

Supplemental Content

Support Center